Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,781,051 papers from all fields of science
Search
Sign In
Create Free Account
androgen suppression
Known as:
Androgen Ablation
, androgen deprivation
Treatment to suppress or block the production or action of male hormones. This is done by having the testicles removed, by taking female sex hormones…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer.
Michael J. Burdick
,
C. Reddy
,
+7 authors
J. Ciezki
International Journal of Radiation Oncology…
2009
Corpus ID: 12912482
Highly Cited
2005
Highly Cited
2005
Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer.
M. Buyyounouski
,
A. Hanlon
,
+4 authors
A. Pollack
International Journal of Radiation Oncology…
2005
Corpus ID: 25520591
Highly Cited
2003
Highly Cited
2003
The 1999 patterns of care study of radiotherapy in localized prostate carcinoma
W. Lee
,
J. Moughan
,
J. Owen
,
M. Zelefsky
Cancer
2003
Corpus ID: 33014880
The objective of the current study was to provide descriptive information on a representative national sample of patients with…
Expand
Review
1999
Review
1999
Overcoming bcl-2- and p53-mediated resistance in prostate cancer.
R. DiPaola
,
J. Aisner
Seminars in Oncology
1999
Corpus ID: 44372173
Most prostate cancers eventually develop resistance to hormonal therapy and chemotherapies. Many mechanisms for resistance to…
Expand
Highly Cited
1998
Highly Cited
1998
5 year biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
A. D'Amico
,
R. Whittington
,
+8 authors
C. Coleman
1998
Corpus ID: 74140090
Review
1998
Review
1998
External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?
A. Pollack
,
G. Zagars
Urology
1998
Corpus ID: 26487148
Highly Cited
1993
Highly Cited
1993
Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor.
J. E. Oesterling
,
P. Andrews
,
V. Suman
,
H. Zincke
,
R. Myers
Journal of Urology
1993
Corpus ID: 29990824
Highly Cited
1993
Highly Cited
1993
Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time.
Gerald E. Hanks
,
Anthony V. D'Amico
,
B. Epstein
,
Timothy E. Schultheiss
International Journal of Radiation Oncology…
1993
Corpus ID: 25801082
Highly Cited
1991
Highly Cited
1991
Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men
Jed P. Weber
,
P. Walsh
,
C. Peters
,
J. Spivak
American journal of hematology/oncology
1991
Corpus ID: 8199217
To examine the role of testosterone in the maintenance of hemoglobin levels, we studied the effect of reversible androgen…
Expand
Highly Cited
1988
Highly Cited
1988
Epidermal growth factor and prostatic carcinoma: an immunohistochemical study.
J. Fowler
,
J. L. Lau
,
L. Ghosh
,
S. Mills
,
A. Mounzer
Journal of Urology
1988
Corpus ID: 24723619
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE